GALT
Galectin Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.61
+5.98%Leverage
- Debt / equity
- -1.01x
- Net debt / equity
- -0.91x
- Debt / assets
- 9.29x
- Debt / EBITDA
- -10.01x
- Net debt / EBITDA
- -9.05x
Liquidity & coverage
- Current ratio
- 0.10x
- Quick ratio
- 0.10x
- Cash ratio
- 0.09x
- Interest coverage
- -2.02x
- EBITDA / interest
- -1.77x
- Working capital
- -$137.0M
Cash & dividend
- FCF / debt
- -0.12x
- Cash flow / debt
- -0.12x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026